comparemela.com

Latest Breaking News On - Analyst recommendations for olema pharmaceuticals - Page 2 : comparemela.com

Analysts Set Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Price Target at $21.00

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has earned an average recommendation of “Buy” from the seven research firms that are currently covering the firm, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have issued ratings on the stock in the last […]

Canada
Sean-bohen
Cyrus-harmon
Olema-pharmaceuticals-stock-down
Virtu-financial
News-ratings-for-olema-pharmaceuticals-daily
Nasdaq
Royal-bank
Citigroup-inc
Olema-pharmaceuticals-inc
Hedge-funds-weigh-in-on-olema-pharmaceuticals
Citigroup

Olema Pharmaceuticals (NASDAQ:OLMA) Now Covered by Citigroup

Olema Pharmaceuticals (NASDAQ:OLMA) Now Covered by Citigroup
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada
Sean-bohen
Naseem-zojwalla
Royal-bank
News-ratings-for-olema-pharmaceuticals-daily
Virtu-financial
Hedge-funds-weigh-in-on-olema-pharmaceuticals
Analyst-recommendations-for-olema-pharmaceuticals
Balyasny-asset-management
Olema-pharmaceuticals
Citigroup
Citigroup-inc

Olema Pharmaceuticals (NASDAQ:OLMA) Now Covered by Citigroup

Analysts at Citigroup started coverage on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Get Free Report) in a report released on Tuesday, Marketbeat reports. The firm set a “buy” rating and a $20.00 price target on the stock. Citigroup’s price target points to a potential upside of 72.12% from the company’s current price. Separately, HC Wainwright […]

Cyrus-harmon
Davidc-myles
Olema-pharmaceuticals-stock
Citigroup
Analyst-recommendations-for-olema-pharmaceuticals
News-ratings-for-olema-pharmaceuticals-daily
Vivo-capital
Olema-pharmaceuticals-company-profile
Institutional-investors-weigh-in-on-olema-pharmaceuticals
Securities-exchange-commission
Dimensional-fund-advisors
Olema-pharmaceuticals-inc

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives $21.20 Average Target Price from Brokerages

Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) have been assigned a consensus rating of “Buy” from the six brokerages that are presently covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have updated their coverage on […]

Canada
Cyrus-harmon
Sean-bohen
Olema-pharmaceuticals-inc
Royal-bank
Nasdaq
Securities-exchange-commission
Virtu-financial
News-ratings-for-olema-pharmaceuticals-daily
Analyst-recommendations-for-olema-pharmaceuticals
Jpmorgan-chase-co
Balyasny-asset-management

Analysts Set Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) PT at $21.20

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has earned an average recommendation of “Buy” from the six research firms that are covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month price objective among analysts that have covered the stock in the […]

G-walmsley-graham
Sean-bohen
Olema-pharmaceuticals-trading
Olema-pharmaceuticals
Nasdaq
Olema-pharmaceuticals-company-profile
News-ratings-for-olema-pharmaceuticals-daily
Dimensional-fund-advisors
Polar-capital-holdings-plc
Olema-pharmaceuticals-inc
Blackrock-inc
Analyst-recommendations-for-olema-pharmaceuticals

vimarsana © 2020. All Rights Reserved.